• Something wrong with this record ?

Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences

L. Jourová, M. Vavreckova, N. Zemanova, P. Anzenbacher, K. Langova, P. Hermanova, T. Hudcovic, E. Anzenbacherova,

. 2020 ; 11 (-) : 01303. [pub] 20201002

Language English Country Switzerland

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc21002022

Sexual differences and the composition/function of the gut microbiome are not considered the most important players in the drug metabolism field; however, from the recent data it is obvious that they may significantly affect the response of the patient to therapy. Here, we evaluated the effect of microbial colonization and sex differences on mRNA expression and the enzymatic activity of hepatic cytochromes P450 (CYPs) in germ-free (GF) mice, lacking the intestinal flora, and control specific-pathogen-free (SPF) mice. We observed a significant increase in the expression of Cyp3a11 in female SPF mice compared to the male group. However, the sex differences were erased in GF mice, and the expression of Cyp3a11 was about the same in both sexes. We have also found higher Cyp2c38 gene expression in female mice compared to male mice in both the SPF and GF groups. Moreover, these changes were confirmed at the level of enzymatic activity, where the female mice exhibit higher levels of functional CYP2C than males in both groups. Interestingly, we observed the same trend as with CYP3A enzymes: a diminished difference between the sexes in GF mice. The presented data indicate that the mouse gut microbiome plays an important role in sustaining sexual dimorphism in terms of hepatic gene expression and metabolism.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc21002022
003      
CZ-PrNML
005      
20210126092708.0
007      
ta
008      
210105s2020 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fphar.2020.01303 $2 doi
035    __
$a (PubMed)33123003
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Jourová, Lenka $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia.
245    10
$a Gut Microbiome Alters the Activity of Liver Cytochromes P450 in Mice With Sex-Dependent Differences. / $c L. Jourová, M. Vavreckova, N. Zemanova, P. Anzenbacher, K. Langova, P. Hermanova, T. Hudcovic, E. Anzenbacherova,
520    9_
$a Sexual differences and the composition/function of the gut microbiome are not considered the most important players in the drug metabolism field; however, from the recent data it is obvious that they may significantly affect the response of the patient to therapy. Here, we evaluated the effect of microbial colonization and sex differences on mRNA expression and the enzymatic activity of hepatic cytochromes P450 (CYPs) in germ-free (GF) mice, lacking the intestinal flora, and control specific-pathogen-free (SPF) mice. We observed a significant increase in the expression of Cyp3a11 in female SPF mice compared to the male group. However, the sex differences were erased in GF mice, and the expression of Cyp3a11 was about the same in both sexes. We have also found higher Cyp2c38 gene expression in female mice compared to male mice in both the SPF and GF groups. Moreover, these changes were confirmed at the level of enzymatic activity, where the female mice exhibit higher levels of functional CYP2C than males in both groups. Interestingly, we observed the same trend as with CYP3A enzymes: a diminished difference between the sexes in GF mice. The presented data indicate that the mouse gut microbiome plays an important role in sustaining sexual dimorphism in terms of hepatic gene expression and metabolism.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Vavreckova, Marketa $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia.
700    1_
$a Zemanova, Nina $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia.
700    1_
$a Anzenbacher, Pavel $u Department of Pharmacology, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia.
700    1_
$a Langova, Katerina $u Department of Medical Biophysics, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia.
700    1_
$a Hermanova, Petra $u Institute of Microbiology, Czech Academy of Sciences, Novy Hradek, Czechia.
700    1_
$a Hudcovic, Tomas $u Institute of Microbiology, Czech Academy of Sciences, Novy Hradek, Czechia.
700    1_
$a Anzenbacherova, Eva $u Department of Medical Chemistry and Biochemistry, Faculty of Medicine and Dentistry, Palacky University, Olomouc, Czechia.
773    0_
$w MED00174597 $t Frontiers in pharmacology $x 1663-9812 $g Roč. 11, č. - (2020), s. 01303
856    41
$u https://pubmed.ncbi.nlm.nih.gov/33123003 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210126092704 $b ABA008
999    __
$a ind $b bmc $g 1614112 $s 1122306
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 11 $c - $d 01303 $e 20201002 $i 1663-9812 $m Frontiers in pharmacology $n Front Pharmacol $x MED00174597
LZP    __
$a Pubmed-20210105

Find record

Citation metrics

Archiving options